RxDoctor Payments Data

Nancy Lehman, MD

Psychiatry · Asheville, NCNPI 1013087105

Payments from drug & device makers

$860in general payments, 2019–2025

Across 45 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$291
  • Teva Pharmaceuticals USA, Inc.$226
  • Otsuka America Pharmaceutical, Inc.$95
  • Indivior Inc.$51
  • Johnson & Johnson$38
  • E.r. Squibb & Sons, L.L.C.$37
  • plus $123 from 5 others

What the payments were for

  • Food & beverage$73986%
  • Education$12114%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$860 in reported general payments places this provider in the 70th percentile of 1,108 psychiatry providers in North Carolina.

See all psychiatry providers in North Carolina

Medicare billing

Part B allowed, 2024
$23,734
Medicare patients
19
Services billed
186

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate52$176,491
Risperdal ConstaRisperidone Microspheres15$38,075
RexultiBrexpiprazole13$19,781
VraylarCariprazine Hcl14$19,569
Clozapine OdtClozapine46$13,855
SeroquelQuetiapine Fumarate12$11,210
Clozapine115$8,376
TrintellixVortioxetine Hydrobromide14$6,252
Vilazodone Hcl13$3,106
Divalproex Sodium ErDivalproex Sodium34$3,006
Risperidone OdtRisperidone13$2,896
Paliperidone ErPaliperidone21$2,470
Aripiprazole72$2,392
Chlorpromazine Hcl12$1,470
Olanzapine49$1,126

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Risperdal Consta$38$214,56667 claims
Otsuka America Pharmaceutical, Inc.Rexulti$95$19,78113 claims
AbbVieVraylar$291$19,56914 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$33$6,25214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,108 psychiatry providers in North Carolina.

Other psychiatry in Asheville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →